Disc Medicine Inc (NAS:IRON)
$ 64.775 6.525 (11.2%) Market Cap: 1.93 Bil Enterprise Value: 1.23 Bil PE Ratio: 0 PB Ratio: 3.94 GF Score: 42/100

Gemini Therapeutics Inc To Discuss Merger with Disc Medicine Inc Call Transcript

Aug 10, 2022 / 12:00PM GMT
Release Date Price: $20.1 (+28.85%)
Unidentified Participant

Welcome to today's joint call with Gemini Therapeutics and Disc Medicine. Our speakers today are George Gemayel, Chair of the Board and Interim CEO of Gemini Therapeutics, and John Quisel, President and CEO of Disc Medicine.

George Gemayel
Gemini Therapeutics, Inc. - Interim CEO & Chair of the Board

Gemini's strategic review was a thorough and thoughtful process. We believe that this transaction presents an exciting opportunity for our shareholders as this has built a diversified clinical-stage pipeline of product candidates. And we believe in the ability of Disc's experienced management team to lead the combined company. We look forward to its continued success. John will now provide an overview of Disc Medicine and the company's hematology drug development programs.

John Quisel
Disc Medicine - President and Chief Executive Officer

Thank you, George, and good morning, everyone. Before I begin, I want to remind everyone that this discussion and the accompanying presentation will contain forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot